Promising malaria vaccine trial launches for children in burkina faso
⭐️ VACCINE ⭐️
Ongoing
This study tests a new malaria vaccine called SUM-101 in 69 healthy children and infants aged 5 months to 5 years in Burkina Faso. The goal is to see if the vaccine is safe and triggers a strong immune response. Participants receive three doses, and some infants also receive a ra…
Phase: PHASE1 • Sponsor: European Vaccine Initiative • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:59 UTC